Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 28, 2018
[Safety Profile of the Combination of Prophylactic Pegfilgrastim and Cabazitaxel for Japanese Patients with Castration Resistant Prostate Cancer]Keiichi Azuma, Kazuyoshi Kawakami, Takeshi Yuasa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 16, 2007
Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patientsTakamitsu Inoue, Takashi Obara, Mitsuru Saito, et al.
International Journal of Clinical Oncology|September 12, 2012
Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinomaYosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, et al.
Cancer Diagnosis & Prognosis|September 6, 2024
Predictors of Progression to Castration-resistant Prostate Cancer After Radical Prostatectomy in High-risk Prostate Cancer PatientsTakato Nishino, Shinya Yamamoto, Noboru Numao, et al.
Anticancer Research|January 2, 2016
Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate CancerMutsushi Yamasaki, Takeshi Yuasa, Shinya Yamamoto, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2008
Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine modelTakeshi Yuasa, Kiyoshi Sato, Eishi Ashihara, et al.
Chemotherapy|July 26, 2014
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor eraHajime Tanaka, Takeshi Yuasa, Yasuhisa Fujii, et al.
Cancer Chemotherapy and Pharmacology|June 10, 2021
Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancerMotohiro Fujiwara, Takeshi Yuasa, Shotaro Yasuoka, et al.
International Journal of Clinical Oncology|September 16, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancerRyo Fujiwara, Kentaro Inamura, Takeshi Yuasa, et al.
IJU Case Reports|September 5, 2023
A case of sequential medical therapy for advanced ureteral cancer in Li-Fraumeni syndromeMinami Une, Ryo Fujiwara, Arisa Ueki, et al.
Pageof 22